Rafael Martínez-Monge1, Alfonso Gómez-Iturriaga. 1. Department of Oncology, Clínica Universitaria de Navarra, University of Navarre, Avenida Pio XII s/n, E-31080 Pamplona, Navarre, Spain. rmartinezm@unav.es
Abstract
PURPOSE: To evaluate the feasibility of high-dose-rate (HDR) brachytherapy in eyelid tumors. No previous reports on HDR brachytherapy for eyelid cancer are found in the literature. METHODS AND MATERIALS: An individual case is reported. A detailed description of the implantation technique, dose prescription, and treatment delivery is provided. RESULTS: The implantation and the treatment course were uneventful. Short-term tolerance was within normal limits. CONCLUSIONS: HDR brachytherapy can be used in patients with eyelid cancer. The larger diameter of HDR applicators compared to LDR wires do not preclude the use of HDR brachytherapy in this structure.
PURPOSE: To evaluate the feasibility of high-dose-rate (HDR) brachytherapy in eyelid tumors. No previous reports on HDR brachytherapy for eyelid cancer are found in the literature. METHODS AND MATERIALS: An individual case is reported. A detailed description of the implantation technique, dose prescription, and treatment delivery is provided. RESULTS: The implantation and the treatment course were uneventful. Short-term tolerance was within normal limits. CONCLUSIONS: HDR brachytherapy can be used in patients with eyelid cancer. The larger diameter of HDR applicators compared to LDR wires do not preclude the use of HDR brachytherapy in this structure.
Authors: M Krengli; L Masini; A M Comoli; E Negri; L Deantonio; A Filomeno; G Gambaro Journal: Strahlenther Onkol Date: 2014-01-16 Impact factor: 3.621